Validation of methods to assess potential biomarkers in pediatric patients with esophageal eosinophilia

doi:10.4292/wjgpt.v4.i4.113

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3830)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

243

HTML

1831

Figures (1-2)

142

Sum=2216

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

810

Download

804

Sum=1614

Nov 6, 2013 (publication date) through May 17, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastrointest Pharmacol Ther. Nov 6, 2013; 4(4): 113-119
Published online Nov 6, 2013. doi: 10.4292/wjgpt.v4.i4.113

Full Size Figure Download Figure

Figure 1 Sample evaluation. A: Tryptase staining for mast cells; B: Grade 0 major basic protein (MBP) involvement (none); C: Grade 1 MBP involvement (< 5%); D: Grade 2 MBP involvement (5%-25%); E: Grade 3 MBP involvement (> 25%); F: Trichrome staining for fibrosis.

Citation: Colombo JM, Neilan NA, Schurman JV, Friesen CA. Validation of methods to assess potential biomarkers in pediatric patients with esophageal eosinophilia. World J Gastrointest Pharmacol Ther 2013; 4(4): 113-119
URL: https://www.wjgnet.com/2150-5349/full/v4/i4/113.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v4.i4.113